Interleukin (IL)-15 Enhances Antibody-Dependent Cellular Cytotoxicity and Natural Killer Activity in Neonatal Cells

This publication has 59 references indexed in Scilit:

• Human Immunodeficiency Virus (HIV) Type-1 GP120-Specific Cell-Mediated Cytotoxicity (CMC) and Natural Killer (NK) Activity in HIV-Infected (HIV+) Subjects: Enhancement with Interleukin-2(IL-2), IL-12, and IL-15
  Clinical Immunology and Immunopathology, 1997
• IL-15: A Pleiotropic Cytokine with Diverse Receptor/Signaling Pathways Whose Expression Is Controlled at Multiple Levels
  Immunity, 1996
• Reduced primary antigen‐specific T‐cell precursor frequencies in neonates is associated with deficient interleukin‐2 production
  Immunology, 1996
• Studies Evaluating the Antitumor Activity and Toxicity of Interleukin-15, a New T Cell Growth Factor: Comparison with Interleukin-2
  Cellular Immunology, 1995
• Age-related changes in surface antigens on peripheral lymphocytes of healthy children
  Clinical and Experimental Immunology, 1995
• Cloning of a T Cell Growth Factor that Interacts with the β Chain of the Interleukin-2 Receptor
  Science, 1994
• Activation of the Human Immature Natural Killer Cell Subset by IL-12 and Its Regulation by Endogenous TNF-α and IFN-γ Secretion
  Cellular Immunology, 1994
• Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients.
  The Journal of Experimental Medicine, 1992
• Defects in interleukin-2 stimulation of neonatal natural killer cytotoxicity to herpes simplex virus-infected cells
  The Journal of Pediatrics, 1988
• A Progress Report on the Treatment of 157 Patients with Advanced Cancer Using Lymphokine-Activated Killer Cells and Interleukin-2 or High-Dose Interleukin-2 Alone
  New England Journal of Medicine, 1987